PATENT CLAIM ANALYSIS

Application Number: 16192162
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-05
Patent Classification: ["546", "273400"]

Abstract:
Novel benzimidazole enantiomeric derivatives, their process of preparation and their therapeutical uses as dual H1 and H4 receptor ligands are disclosed.

Claim (Index 8):
The method according to  claim 7 , where the inflammatory disorder is chosen from anaphylactic shock, respiratory inflammatory and allergic diseases, adult respiratory distress syndrome, acute respiratory distress syndrome, respiratory infections, bronchitis, chronic bronchitis, chronic obstructive pulmonary disease, cystic fibrosis, asthma, emphysema, rhinitis, rhinorrhea, chronic sinusitis, allergy, allergy-induced airway responses, allergic rhinitis, viral rhinitis, non-allergic rhinitis, perennial and seasonal rhinitis, conjunctivitis, allergic conjunctivitis, otitis, nasal polyps, vaugh, ocular itching, chronic urticaria, eczema, prurigo, pruritus cutaneous, erythema exsudativum, nasal congestion, allergic congestion; disorders of the genito-urinary tract such as female and male sexual dysfunction, overactive bladder conditions, urinary incontinence, bladder overactivity, benign prostate hyperplasia and lower urinary tract symptoms; dermatological diseases such as dermatitis, atopic dermatitis, and psoriasis and itchy skin; pruritus, skin incision model of postoperative pain, allergic skin disease/itching and inflammation, allergic contact dermatitis, itching associated with hepatic or kidney insufficiency; diseases of the cardiovascular system including thromboembolic diseases, atherosclerosis, myocardial infarction, angina pectoris, myocardial ischemia, arrhythmia, peripheral arterial occlusive diseases, pulmonary embolisms deep venous thromboses, hypotension, pulmonary hypertension, angioedema, malignant hypertension, cardiac insufficiency, heart or kidney failure, stroke and renal dysfunction; diseases of the gastrointestinal tract including inflammatory bowel disease, Crohn's disease, ulcerative colitis; intestinal anaphylaxis, food allergy, post inflammatory visceral hypersensitivity, peritonitis, autoimmune diseases including rheumatoid arthritis, multiple sclerosis, lupus, osteoarthritis joint pain, general inflammation; cancer; pain, neuropathic pain, chronic hyper-eosinophilias, chronic diseases associated with mast cell multiplication; lymphatic diseases.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 98.0
- Lexical Diversity: 1.09524
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13825989', '14317024', '13910651', '10582564', '14058164']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7800579257199589
- 35 USC 102 Novelty (BERT): 0.5404725744836588
- Combined Prediction Score: 0.7560993905963289
- Mean Citation Score: 322.902672
- Max Citation Score: 392.15402
- Similarity Product: 164.76272139890605

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test